Results 241 to 250 of about 1,390,389 (383)

Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. [PDF]

, 1965
W.M. Court Brown, Richard Doll
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

RTPhy-ChatBot: A RAG-Based intelligent assistant for radiotherapy physics using LLaMA3 and AAPM reports. [PDF]

J Appl Clin Med Phys
Wei S, Hu A, Wang Z, Meng X, Yu L, Yang B, Qiu J.   +6 more
europepmc   +1 more source

Tumor Extent as A Determining Factor in Radiotherapy of Glioblastomas [PDF]

, 1969
Simon Krämer
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Interrogating ABCC1 and CASP1 as key players in epigallocatechin gallate's action against radiotherapy-resistant nasopharyngeal carcinoma. [PDF]

Sci Rep
Feng Z, Yang Y, Xie Z, Zuo L, Li Z, Wei C, Li J, Gao Y, Li Z, Zuo D, Liu Q, Xuan G, Luo W, Tang X, Yi S, Liu F, Ma N, Murata M, He F.   +18 more
europepmc   +1 more source

Results of Treatment in Glomus Jugulare Tumors with Emphasis on Radiotherapy [PDF]

, 1962
J. D. R. Miller
openalex   +1 more source

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Nature Reviews. Cancer, 2015
H. Barker, J. Paget, A. Khan, K. Harrington   +3 more
semanticscholar   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?

Chinese Journal of Cancer, 2017
Alexis Vallard, Chloé Rancoule, Jean-Baptiste Guy, Avi Assouline, Alexander T. Falk, Pierre Auberdiac, Julien Langrand-Escure, Cyrus Chargari, Nicolas Magné   +8 more
doaj   +1 more source